healthcare
KKR backs Australia ultrasound start-up
KKR has committed $35 million to Signostics, an Australian medical technology company that produces hand-held devices used to conduct ultrasound tests and bladder scans.
Lyfe Capital closes debut China healthcare fund at $298m
Shanghai-based healthcare-focused PE firm Lyfe Capital has closed its debut China fund at $298 million.
Sequoia, Medtronic establish China medical technology fund
Sequoia Capital has partnered with global medical equipment manufacturer Medtronic to form a China-focused medical technology investment fund worth $60 million.
WuXi Pharmatech wins endorsement for PE-backed take-private
The proposed privatization of WuXi PharmaTech, a China-based provider of contract R&D services to the global pharmaceutical sector, has won the support of two major shareholder proxy advisory firms.
PE-backed Wenzhou Kangning Hospital targets $88m in HK IPO
Wenzhou Kangning Hospital, a private psychiatric specialty care service provider in China with several PE investors, has priced its Hong Kong IPO to raise as much as HK$681 million ($88 million).
Biosensors agrees to CITIC Private Equity buyout
The board of Singapore-listed medical devices manufacturer Biosensors International has accepted a buyout offer from CITIC Private Equity that values the company at approximately S$1.4 billion ($996 million).
PE firms target China services sector liberalization - AVCJ Forum
The liberalization of China’s services sector represents a significant opportunity for private equity, although investors must think carefully about targeting appropriate areas and finding the right partners.
Lilly Asia commits $15m to China cancer drug developer
Lilly Asia Venture has provided a Series A round of funding worth $15 million for MabSpace Bioscience, a China-based company focused on developing cancer therapies.
CITIC PE seeks full ownership of Biosensors International
CITIC Private Equity has submitted a buyout offer for Biosensors International, a Singapore-listed medical devices manufacturer in which it already holds close to a 20% stake.
OrbiMed leads $50m round for India's Netmeds
Healthcare focused investment firm OrbiMed has led a $50 million round of funding for Indian online drug marketplace Netmeds.
PE-backed China drug developer files for US IPO
BeiGene, a Chinese company backed by the likes of Hillhouse Capital and CITIC Private Equity that develops drugs to treat cancer, has filed for an IPO in the US.
China's Wuxi Healthcare VC joins round for US genetics start-up
Wuxi Healthcare Venture, a corporate venture fund owned by China-based Wuxi Pharmatech, has participated in a $115 million Series E round of funding for 23andMe, a Silicon Valley-based genetics-testing company.
Good Resources, Bank of China set up $5b global M&A fund
Good Resources Holdings, a Hong Kong-listed investment firm controlled by Chinese billionaire Kin-Ming Cheng, will set up a joint global MA& fund worth $5 billion in conjunction with Bank of China’s Hong Kong asset management unit.
Australian LPs and domestic VC: Toe in the water
Australian super funds are showing renewed interests in domestic venture capital, supporting firms that offer flexible structures with co-investment opportunities. Can this approach work for all GPs?
IDG leads $15m round for China healthcare start-up
IDG Capital Partners has led a $15 million Series A round for Zhangshang Tangyi, a Chinese start-up that is developing a health data tracking device and mobile app for people with diabetes.
Lippo sponsors Southeast Asia VC fund
Former Monk's Hill Ventures partner Stefan Jung has announced the launch of Venturra Capital, a new Southeast Asia-focused VC fund backed by the Lippo Group.
China’s CreditEase reaches first close on Israel fund
CreditEase, a leading Chinese peer-to-peer (P2P) microcredit lender, has reached a first close of $30 million on its debut Israel-focused fund.
Vertex raises $600m for China, US, Israel investments
Vertex Ventures, the VC arm of Singapore's Temasek Holdings, has received $600 million from its parent to invest in start-ups in China, the US and Israel.
Deal focus: Portea takes healthcare to the home
Accel leads a $37.5 million round for Portea Medical, an India-based home healthcare business set up by the founders of TutorVista
Hillhouse, Goldman lead $394m round for China healthcare portal
Guahao.com, a Chinese healthcare information portal, has completed a Series B round of funding worth $394 million led by Hillhouse Capital and Goldman Sachs.
India home healthcare provider gets $37.5m
Accel Partners has led a $37.5 million Series B round for home healthcare start-up Portea Medical, with participation from the International Finance Corporation (IFC), Qualcomm Ventures, and Ventureast.
Deal focus: Hao recommits to hospital modernization
Hao Capital to support the continued roll-out of DJ HealthUnion's hospital IT solutions platform in China
Olympus commits $40m to China's Tendcare Medical
Olympus Capital Asia has invested $40 million in Chinese private hospital manager Tian Jian Hua Xia Medical Group Holdings, or Tendcare Medical Group.
Hao Capital invests $12.5m in China's DJ Health Union
China-focused GP Hao Capital has invested $12.5 million in DJ HealthUnion Systems Corporation, which specializes in providing health data sharing solutions to hospitals.